 | Up a level |
Bloch, W., Baumann, F., Zimmer, P., Grischke, E-M, Fasching, P. A., Decker, T., Uleer, C., Schneeweiss, A., Salat, C., Wimberger, P., Mundhenke, C., Foerster, F., Kluth-Pepper, B., Schubert, J., Tesch, H., Schuetz, F., Lueftner, D. and Jackisch, C. (2016). Impact of physical activity/exercise on adverse events and quality of life during treatment with everolimus and exemestane for ER plus women - Results of the 3rd interim analysis of BRAWO. Cancer Res., 76. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445
Hillemanns, P., Woelber, L., Jueckstock, J., Neuser, P., Hilpert, F., Harter, P., De Gregorio, N., Hasenburg, A., Sehouli, J., Habermann, A., Fuerst, S. T., Strauss, H. -G., Baumann, K., Thiel, F., Mustea, A., Meier, W., Du Bois, A., Wimberger, P., Hanker, L., Schmalfeldt, B., Canzler, U., Fehm, T., Luyten, A., Hellriegel, M., Kosse, J., Heiss, C., Hantschmann, P., Mallmann, P., Tanner, B., Pfisterer, J., Richter, B., Petersen, C. and Mahner, S. (2014). AGO Vulva CaRE-1 multicenter study - adjuvant radio(chemo)therapy in vulvar cancer. Oncol. Res. Treat., 37. S. 70 - 71. BASEL: KARGER. ISSN 2296-5262
Jueckstock, J., Fuerst, S., Bommert, M., Harter, P., Prieske, K., Eulenburg, C., Hilpert, F., deGregorio, N., Iborra, S., Sehouli, J., Ignatov, A., Hillemanns, P., Jaeger, A., Strauss, H-G, Baumann, K., Thiel, F., Mustea, A., Meier, W., Wimberger, P., Hanker, L., Schmalfeldt, B., Canzler, U., Fehm, T., Luyten, A., Hellriegel, M., Kosse, J., Heiss, C., Hantschmann, P., Mallmann, P., Tanner, B., Pfisterer, J., Woelber, L. and Mahner, S. (2020). Importance of pelvic Lymphonodectomy in Squamous Cell Carcinoma of the Vulva (VSCC) Subgroup Analysis of the AGO-CaRE-1 Study. Geburtshilfe Frauenheilkd., 80 (7). S. 740 - 741. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Link, T., Blohmer, J-U., Just, M., Untch, M., Stoetzer, O., Fasching, P. A., Schneeweiss, A., Wimberger, P., Seiler, S., Huober, J., Schmitt, W. D., Jackisch, C., Rhiem, K. E., Hanusch, C., Denkert, C., Sinn, B. V., Engels, K., Nekljudova, V. and Loibl, S. (2020). GeparX: Denosumab (Dmab) as add-on to different regimen of nab-paclitaxel (nP)-anthracycline based neoadjuvant chemotherapy (NACT) in early breast cancer (BC): Subgroup analyses by RANK expression and HR status. Ann. Oncol., 31. S. S308 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Lueftner, D., Grischke, E. M., Fasching, P., Decker, T., Schneeweiss, A., Uleer, C., Foerster, F., Wimberger, P., Kluth-Pepper, B., Schubert, J., Bloch, W., Tesch, H., Schuetz, F. and Jackisch, C. (2015). Disease characteristics of subgroup patients treated with everolimus plus exemestane for < 12 months, >= 12 to < 18months, and >= 18 months - Results of the 3rd interim analysis of the non-interventional trial BRAWO. Eur. J. Cancer, 51. S. S288 - 2. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852
Prieske, K., Woelber, L., Muallem, M. Z., Eulenburg, C., Jueckstock, J., Hilpert, F., de Gregorio, N., Iborra, S., Ignatov, A., Hillemanns, P., Fuerst, S. T., Strauss, H. G., Baumann, K., Thiel, F., Mustea, A., Meier, W., Harter, P., Wimberger, P., Hanker, L., Schmalfeldt, B., Canzler, U., Fehm, T., Luyten, A., Hellriegel, M., Kosse, J., Heiss, C., Hantschmann, P., Mallmann, P., Tanner, B., Pfisterer, J., Sehouli, J. and Mahner, S. (2020). The influence of age on treatment and prognosis of patients with squamous cell vulvar cancer (VSCC)- a subset analysis of the AGO-CaRE-1 study. Geburtshilfe Frauenheilkd., 80 (10). S. E201 - 2. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Reinisch, M., Blohmer, J-U., Link, T., Just, M., Untch, M., Stoetzer, O., Fasching, P. A., Schneeweiss, A., Wimberger, P., Seiler, S., Huober, J., Thill, M., Jackisch, C., Rhiem, K., Solbach, C., Hanusch, C., Denkert, C., Engels, K., Nekljudova, V. and Loibl, S. (2022). Patient quality of life (QoL) from the GeparX trial on the addition of denosumab (Dmab) added to two different nab-paclitaxel (nP) regimens as neoadjuvant chemotherapy (NACT) in primary breast cancer (BC). Ann. Oncol., 33. S. S166 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Schott, S., Kuhlmann, J. D., Klink, B., Gruetzmann, K., Puppe, J., Wauer, U. S., Klotz, D. M., Schroeck, E. and Wimberger, P. (2018). The conjugated antimetabolite 5-FdU-ECyd and its cellular and molecular effects on platinum-sensitive vs. -resistant ovarian cancer cells in vitro. Oncol. Res. Treat., 41. S. 84 - 85. BASEL: KARGER. ISSN 2296-5262
Schuering, A. N., Fehm, T., Behringer, K., Goeckenjan, M., Wimberger, P., Henes, M., Henes, J., Fey, M. F. and von Wolff, M. (2018). Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation. Arch. Gynecol. Obstet., 297 (1). S. 241 - 256. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-0711
Schuetz, F., Grischke, E-M, Decker, T., Uleer, C., Schneeweiss, A., Salat, C., Wimberger, P., Mundhenke, C., Foerster, F., Kluth-Pepper, B., Schubert, J., Bloch, W., Tesch, H., Jackisch, C., Idiftner, D. and Fasching, P. A. (2016). Stomatitis in patients treated with everolimus and exemestane - Results of the 3rd interim analysis of the non-interventional trial BRAWO. Cancer Res., 76. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445
Tesch, H., Grischke, E-M, Fasching, P., Decker, T., Uleer, C., Schneeweiss, A., Foerster, F., Wimberger, P., Kluth-Pepper, B., Schubert, J., Bloch, W., Jackisch, C., Schuetz, F. and Lueftner, D. (2015). Results of the 3rd interim analysis of BRAWO - breast cancer treatment with everolimus and exemestane for ER plus women. Oncol. Res. Treat., 38. S. 252 - 254. BASEL: KARGER. ISSN 2296-5262
Tesch, H., Grischke, E-M, Fasching, P. A., Decker, T., Uleer, C., Schneeweiss, A., Salat, C., Wimberger, P., Mundhenke, C., Foerster, F., Kluth-Pepper, B., Schubert, J., Bloch, W., Jackisch, C., Schuetz, F. and Lueftner, D. (2016). Results of the 3rd interim analysis of the non-interventional trial BRAWO - Subanalysis of patients < 70 years and >= 70 years. Cancer Res., 76. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445
Woelber, L., Jueckstock, J., Hilpert, F., Neuser, P., Harter, P., De Gregorio, N., Iborra, S., Sehouli, J., Habermann, A., Hillemanns, P., Fuerst, S., Strauss, H. -G., Baumann, K. H., Thiel, F., Mustea, A., Meier, W., Du Bois, A., Wimberger, P., Hanker, L. C., Schmalfeldt, B., Canzler, U., Fehm, T., Luyten, A., Hellriegel, M., Kosse, J., Heiss, C., Hantschmann, P., Mallmann, P., Tanner, B., Pfisterer, J., Richter, B., Griebel, L. -F. and Mahner, S. (2014). Outcome parameters in node-negative vulvar cancer - subset analysis of the AGO CaRE-1 study. Oncol. Res. Treat., 37. S. 72 - 74. BASEL: KARGER. ISSN 2296-5262